Therapeutic Group: Anti Viral, Hepatitis B Medication Presentation Each tablet contains Tenofovir Disoproxil Fumarate INN 300 mg. Description Tenofovir Disoproxil Fumarate, an acyclic nucleotide analog of adenosine monophosphate, is a prodrug of Tenofovir. It shows activity against HBV polymerase and HIV reverse transcriptase after phosphorylation to the active diphosphate form. Tenofovir diphosphate inhibits viral polymerase […]
Therapeutic Group: Anti Viral, Hepatitis B Medication Presentation Alfavir : Each tablet contains Tenofovir Alafenamide INN 25 mg. Description Tenofovir Alafenamide, a hepatitis B virus (HBV) nucleoside analog reverse transcriptase inhibitor, is converted into tenofovir, an acyclic nucleoside phosphonate (nucleotide) analog of adenosine 5′-monophosphate. Indications Tenofovir Alafenamide is indicated for the treatment of chronic hepatitis […]
Therapeutic Group: Cardiovascular Presentation Telmidip 40/5: Each tablet contains Telmisartan BP 40 mg and Amlodipine Besilate BP equivalent to Amlodipine 5 mg. Telmidip 80/5: Each tablet contains Telmisartan BP 80 mg and Amlodipine Besilate BP equivalent to Amlodipine 5 mg. Telmidip 40/10: Each tablet contains Telmisartan BP 40 mg and Amlodipine Besilate BP equivalent to […]
Therapeutic Group: Cardiovascular Presentation Telmipres Plus 40/12.5: Each tablet contains Telmisartan BP 40 mg & Hydrochlorothiazide BP 12.5 mg. Telmipres Plus 80/12.5: Each tablet contains Telmisartan BP 80 mg & Hydrochlorothiazide BP 12.5 mg. Telmipres Plus 80/25: Each tablet contains Telmisartan BP 80 mg & Hydrochlorothiazide BP 25 mg. Description Telmisartan blocks the vasoconstrictor and […]
Therapeutic Group: Cardiovascular Presentation Telmipres 20: Each tablet contains Telmisartan BP 20 mg. Telmipres 40: Each tablet contains Telmisartan BP 40 mg. Telmipres 80: Each tablet contains Telmisartan BP 80 mg. Description Telmisartan blocks the vasoconstrictor and aldosterone-secreting effects of angiotensin II by selectively blocking the binding of angiotensin II to the AT1 receptor in […]
Therapeutic Group: Glycopeptide antibiotic Presentation Tergocin 200 IM/IV Injection/Infusion: Each vial contains Teicoplanin BP 200 mg as lyophilized cake or powder. Tergocin 400 IM/IV Injection/Infusion: Each vial contains Teicoplanin BP 400 mg as lyophilized cake or powder Description Teicoplanin is a glycopeptide antibiotic that has shown in vitro bactericidal activity against both anaerobic and aerobic […]
Therapeutic Group: Oxazolidiones Presentation TezolidTM Tablet: Each tablet contains Tedizolid Phosphate INN 200 mg. TezolidTM IV Infusion: Each vial contains Tedizolid Phosphate INN 200 mg as lyophilized powder for IV infusion. Description Tedizolid is an oxazolidinone-class antibiotic indicated for the treatment of acute bacterial skin and skin structure infections caused by susceptible isolates of the […]
Therapeutic Group: Skin Presentation Tazoskin cream: Each gm Tazoskin cream contains Tazarotene INN 1mg Description Topical Tazarotene blocks ornithine decarboxylase (ODC) activity, which is associated with cell proliferation and hyperplasia. Tazarotene suppresses expression of MRP8, a marker of inflammation present in the epidermis of psoriasis patients at high levels. In human keratinocyte cultures, it inhibits […]
Therapeutic Group: Urological Presentation Prostacin Capsule: Each modified release capsule contains Tamsulosin Hydrochloride USP 0.4 mg (as modified release Pellets). Description Tamsulosin, a selective alpha1 adrenoceptor blocking agent, exhibits its selectivity for alpha1A adrenoceptors in human prostate. Blockade of these adrenoceptors can cause smooth muscle in the bladder neck and prostate to relax, resulting in […]
Therapeutic Group: Urological Presentation Tadalis 10 tablet: Each tablet contains 10 mg of Tadalafil INN. Description Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide; inhibition of PDE5 by Tadalafil produces increased levels of cGMP in the corpus cavernosum. […]